Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,464 signal articles · 149 in last 24h · 154,171 total before filter · latest 1h ago
149last 24h
875last 7d
144● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings109M&A125Regulatory21Product21Analyst18
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Apple Faces £2 Billion UK Lawsuit Over App Tracking Transparency Rules
InvestorsHub21d agobearish
Apple Faces £2 Billion UK Lawsuit Over App Tracking Transparency Rules

Apple (NASDAQ:AAPL) is facing a £2 billion ($2. 7 billion) lawsuit in London brought on behalf of app developers over its App Tracking Transparency rules, with the claim alleging that the company imposed stricter requirements on third-party developers than on its own services.

Ford Faces Another Quality Test as Mustang Recall Raises Fresh Concerns
Insider Monkey22d agobearish
Ford Faces Another Quality Test as Mustang Recall Raises Fresh Concerns

Ford Motor Company (NYSE:F) is recalling 148,663 Mustang vehicles in the US from the 2024 to 2026 model years because engine-compartment wiring harness ground connections could fracture. The defect can potentially cause a loss of drive power and disable functions such as the headlights, windshield washer system, air conditioning, and engine cooling fan, increasing the […]

Google Gemini Integration and AI Lawsuits Could Be A Game Changer For Wix.com (WIX)
Simply Wall St.22d agobearish
Google Gemini Integration and AI Lawsuits Could Be A Game Changer For Wix.com (WIX)

Wix.com Ltd. previously announced a collaboration with Google to embed its Wix Harmony website creation tools directly inside Gemini as a connected app, allowing users to build, manage, and analyze full-featured sites through natural-language interactions without leaving the Gemini interface. At the same time, multiple securities class action filings now question prior disclosures about the competitiveness and cost profile of Wix’s AI products, putting added scrutiny on how initiatives like...

What Does Apple (AAPL) Risk From Its Trade Secrets Lawsuit?
Simply Wall St.23d agobearish
What Does Apple (AAPL) Risk From Its Trade Secrets Lawsuit?

Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI and a former engineer over alleged theft of confidential circuit schematics and related trade secrets. The complaint accuses the former Apple employee of misappropriating proprietary hardware designs and integrating them into OpenAI projects. Apple is seeking damages, a preliminary injunction, and court orders to destroy any materials that allegedly contain its protected technology. The case adds fresh scrutiny to how major AI players...

Elon Musk Recalls SpaceX Nearly Failing After 3 Rocket Launches: ‘If the 4th Launch Had Failed, SpaceX Would Not Exist’
Benzinga23d agobearish
Elon Musk Recalls SpaceX Nearly Failing After 3 Rocket Launches: ‘If the 4th Launch Had Failed, SpaceX Would Not Exist’

While Space Exploration Technologies Corp. (NASDAQ:SPCX) is one of the biggest enterprises in the world today, this was not always the case, as CEO Elon Musk shared how repeated initial launch failures cast uncertainty over the future of the commercial spaceflight company. Peter Diamandis Recalls SpaceX’s Failures In a post on X on Sunday, X Prize Foundation‘s Executive Chairman Peter Diamandis shared how everyone knows the “trillion-dollar version of SpaceX,” but nobody remembered that “Elon’s

Amazon stock falls as FTC prepares ad-pricing lawsuit
InvestorsHub24d agobearish
Amazon stock falls as FTC prepares ad-pricing lawsuit

Key takeawaysThe FTC and more than 20 state attorneys general reportedly plan to sue Amazon over its advertising-auction practices. Regulators are expected to allege that undisclosed price floors increased advertisers’ costs and generated tens of billions of dollars for Amazon.

Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment
MarketBeat24d agobullish
Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment

Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M

Eli Lilly (LLY) Stock May Be 30% Undervalued Despite Fresh FDA Approval
Simply Wall St.24d agoneutral
Eli Lilly (LLY) Stock May Be 30% Undervalued Despite Fresh FDA Approval

Eli Lilly stock has delivered very strong gains over the past five years. Current checks give a mixed read on valuation, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside, while market based multiples look closer to fair. Eli Lilly has returned 373.6% over five years, which puts a lot of optimism into the share price and raises the bar for what counts as good value today. The expanded use of drugs like Mounjaro and Zepbound in metabolic and cardiovascular care...

Tesla (TSLA) Recalls 3 Million China EVs Over Door Handles, Driver Monitoring
Insider Monkey27d agobearish
Tesla (TSLA) Recalls 3 Million China EVs Over Door Handles, Driver Monitoring

On August 21, CNBC reported that according to notices published by Tesla and China’s State Administration for Market Regulation, Tesla, Inc. (NASDAQ:TSLA) is voluntarily recalling about 3 million vehicles in China over two separate issues: door handles that can fail to open after severe crashes and deficient driver “attention monitoring” systems. The door handle flaw […]

New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth Catalyst
Insider Monkey28d agoneutral
New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth Catalyst

The U.S. FDA has approved Bristol-Myers Squibb Company (NYSE:BMY)’s oral blood-cancer drug iberdomide, sold as Zenbexus, for patients with relapsed or refractory multiple myeloma. The treatment is given with Johnson & Johnson’s Darzalex and dexamethasone. The approval gives BMY another product that could support growth in its oncology business. Iberdomide belongs to a newer class […]

KKR Hit With $250 Million Penalty Over Antitrust Violations
Benzinga Private Markets28d agoneutral
KKR Hit With $250 Million Penalty Over Antitrust Violations

KKR & Co. (NYSE:KKR) is set to pay a $250 million civil penalty after the private equity firm allegedly violated the Hart-Cottrell-Rodino Act by withholding and altering documents and failing to make required filings. The HSR Act requires M&A parties...